Breast Cancer Canada warmly invites you to Canadian Night at ASCO 2026, a special evening to connect with Canadian researchers, patient advocates, and healthcare leaders while celebrating progress in breast cancer research.
Event Details:
Date: Saturday, May 30, 2026
Time: 6:00 PM – 8:00 PM
Location: Burnham Ballroom, JW Marriott Chicago – 4th Floor
151 W Adams St, Chicago, IL 60603
A Venue with History and Charm
The Burnham Ballroom is a historic and elegant space, featuring a 30-foot barrel-vaulted ceiling, hand-blown glass chandeliers, and original 1914 banking hall details. This iconic venue combines classic charm with modern amenities, providing a stunning backdrop for networking, conversation, and celebration.
Join Us at ASCO 2026
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the most influential cancer research conferences in the world. Breast Cancer Canada (BCC) is proud to host Canadian Night at ASCO 2026: a premier networking event designed to unite Canada’s brightest minds in breast cancer research and care.
Join Kimberly Carson, CEO of Breast Cancer Canada, and Shaniah Leduc, Board Chair, as we bring together leading Canadian researchers, clinicians, and industry partners to discuss the latest advancements shaping the future of cancer treatment.
All Canadians attending ASCO are welcome, regardless of the tumour type your work supports. Registration is complimentary, but advance registration is requested to ensure an optimal experience with food and beverages.
Why Attend?
- Collaborate: Connect with top experts and emerging leaders in Canadian breast cancer research.
- Explore Innovations: Engage in discussions about the latest advancements in breast cancer treatment and precision medicine.
- Expand Your Network: Build partnerships with key stakeholders across research, clinical practice, and industry.
Breast Cancer Canada is committed to ensuring that Canadian research and patient perspectives continue to drive global progress in breast cancer care.
This event is made possible through the generous support of Exact Sciences, a valued partner in our mission to accelerate research and improve outcomes for patients.
